Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeEAM Conditioning for ASCT in Aggressive NHL
NCT01296256Phase 2Completed
- Sponsor
- GELTAMO
- Start
- May 2011
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in non-Hodgkin lymphoma (NHL), sponsored by GELTAMO. Started May 2011; status: completed.
02
Drugs
bendamustine
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01296256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296256.